Lloyd Mitchell Segal
Net Worth
Last updated:
What is Lloyd Mitchell Segal net worth?
The estimated net worth of Mr. Lloyd Mitchell Segal is at least $6,526,868 as of 1 Apr 2024. He owns shares worth $163,488 as insider, has earned $1,971,530 from insider trading and has received compensation worth at least $4,391,850 in Repare Therapeutics Inc..
What is the salary of Lloyd Mitchell Segal?
Mr. Lloyd Mitchell Segal salary is $878,370 per year as Pres, Chief Executive Officer & Director in Repare Therapeutics Inc..
How old is Lloyd Mitchell Segal?
Mr. Lloyd Mitchell Segal is 61 years old, born in 1964.
What stocks does Lloyd Mitchell Segal currently own?
As insider, Mr. Lloyd Mitchell Segal owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Repare Therapeutics Inc. (RPTX) | Pres, Chief Executive Officer & Director | 107,558 | $1.52 | $163,488 |
What does Repare Therapeutics Inc. do?
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that focuses on genomic instability, including DNA damage repair. Its lead product candidate is RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It is also developing RP-6306, which is under Phase I clinical trial for tumors with genetic alterations characterized by CCNE1 amplification; and Polymerase Theta program, a SL target associated with BRCA mutations and other genomic alterations. The company was incorporated in 2016 and is headquartered in Montreal, Canada.
Lloyd Mitchell Segal insider trading
Repare Therapeutics Inc.
Mr. Lloyd Mitchell Segal has made 14 insider trades between 2020-2024, according to the Form 4 filled with the SEC. Most recently he sold 2,491 units of RPTX stock worth $11,533 on 1 Apr 2024.
The largest trade he's ever made was exercising 300,000 units of RPTX stock on 18 Jan 2022. As of 1 Apr 2024 he still owns at least 107,558 units of RPTX stock.
Repare Therapeutics key executives
Repare Therapeutics Inc. executives and other stock owners filed with the SEC:
- Dr. Maria Koehler M.D., Ph.D. (68) Executive Vice President & Chief Medical Officer
- Dr. Michael Zinda Ph.D. (54) Executive Vice President & Chief Scientific Officer
- Mr. Lloyd Mitchell Segal (61) Pres, Chief Executive Officer & Director